colon cancer | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'colon cancer'

National Cancer Institute Director Neil Sharpless says mortality from delays in cancer screenings due to COVID19 pandemic could result in tens of thousands of extra deaths in next decade

Posted in Cancer - General, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Prevention: Research & Programs, Cancer Researchers Fighting COVID-19, Cancer Screening, coronavirus, Coronavirus Gene Expression, COVID-19: Pandemic Surgery Guidance, number of asymptomatic infections, Patient Experience, SARS-CoV-2, Treatment Protocols for COVID-19, tagged #COVID-19, #COVID19andcancer, breast cancer, breast cancer screening, colon cancer, colon cancer screening, coronavirus, COVID-19, NCI, SARS-CoV-2 on June 25, 2020| Leave a Comment »

National Cancer Institute Director Neil Sharpless says mortality from delays in cancer screenings due to COVID19 pandemic could result in tens of thousands of extra deaths in next decade Reporter: Stephen J Williams, PhD UPDATED: 10/11/2021 Source: https://cancerletter.com/articles/20200619_1/ NCI Director’s Report Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and […]

Read Full Post »

NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese

Posted in Cancer - General, Cancer and Current Therapeutics, Cancer Informatics, Childhood cancer, Clinical & Translational, Curation, Global Medical Publishers by Country, Health Care System by Country, LPBI Management, Personal Health Applications: Tech Innovations serves HealhCare, Pharmaceutical Industry Competitive Intelligence, Pharmacovigilance, Population Health Management, Prostate Cancer: Monitoring vs Treatment, Scientific Publishing, tagged Brazil, breast cancer, Cancer, cancer treatment, Clinical decision support system, clinical trial guidelines, colon cancer, FDA, FDA guidance, Latin America, LPBI, Medical guideline, medical text, national cancer institute, National Comprehensive Cancer Network, NCCN, Regulatory, Spanish, translation, treatment decisions, treatment guidance on September 14, 2021| Leave a Comment »

NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese Reporter: Stephen J. Williams, Ph.D. Currently many biomedical texts and US government agency guidelines are only offered in English or only offered in different languages upon request. However Spanish is spoken in a majority of countries worldwide and medical text in that language […]

Read Full Post »

Cancer Genomics: Multiomic Analysis of Single Cells and Tumor Heterogeneity

Posted in Anticancer Resistance, Artificial Intelligence - General, Bio-MEMS, Biological Networks, Biological Networks, Gene Regulation and Evolution, Cancer - General, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Informatics, Cell Biology, Cell Biology, Signaling & Cell Circuits, Gene Regulation, Genome Biology, Methylation, Single Cell Genomics, Single-cell sequencing, tagged colon cancer, diagnostic genomics, DNA methylation, Omics, single cell, Single Cell Genomics, Transcriptomics on October 15, 2019| Leave a Comment »

Cancer Genomics: Multiomic Analysis of Single Cells and Tumor Heterogeneity Curator: Stephen J. Williams, PhD 4.3.7 Cancer Genomics: Multiomic Analysis of Single Cells and Tumor Heterogeneity, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 4: Single Cell Genomics scTrio-seq identifies colon cancer lineages Single-cell […]

Read Full Post »

Lesson 9 Cell Signaling: Curations and Articles of reference as supplemental information for lecture section on WNTs: #TUBioll3373

Posted in Anticancer Resistance, Apoptosis, Biochemical pathways, Biological Networks, Biological Networks, Gene Regulation and Evolution, Breast Cancer - impalpable breast lesions, Ca2+ triggered activation, Calcium, Calcium Signaling, Calmodulin, Calmodulin Kinase and Contraction, Cancer - General, Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Genomics, Cell Biology, Cell Biology, Signaling & Cell Circuits, Competition in regenerative stem cell science, Curation, Loss of function gene, Phosphorylation, Scientific Publishing, Signaling, Ubiquitinylation, Uncategorized, tagged #TUBiol3373, actin, APC, breast cancer, Cancer, Cell Motility, colon cancer, epithelial ovarian cancer, Extracellular matrix, Hepatocellular carcinoma, HNPCC, noncanonical, tumor associated fibroblasts, Ubiquitin, Wnt signaling, Wnt signaling pathway, wnt-beta/catenin signaling on May 1, 2018| Leave a Comment »

Lesson 9 Cell Signaling: Curations and Articles of reference as supplemental information for lecture section on WNTs: #TUBiol3373 Stephen J. Wiilliams, Ph.D: Curator UPDATED 4/23/2019 This has an updated lesson on WNT signaling. Please click on the following and look at the slides labeled under lesson 10 cell motility 9b lesson_2018_sjw Remember our lessons on […]

Read Full Post »

Medical Startups – Artificial Intelligence (AI) Startups in Healthcare

Posted in Academic Publishing, Advanced Computing Platform, Artificial Intelligence - General, Artificial Intelligence Applications in Health Care, Artificial Intelligence in CANCER, Artificial Intelligence in Health Care - Tools & Innovations, Big Data, BioIT: BioInformatics, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, Machine Learning, Natural Language Processing (NLP) on March 2, 2022| 1 Comment »

Medical Startups – Artificial Intelligence (AI) Startups in Healthcare Reporters: Stephen J. Williams, PhD and Aviva Lev-Ari, PhD, RN and Shraga Rottem, MD, DSc, The motivation for this post is two fold: First, we are presenting an application of AI, NLP, DL to our own medical text in the Genomics space. Here we present […]

Read Full Post »

Pfizer buys out Array BioPharma for $11.4 Billion to beef up its oncology offerings

Posted in Drug Development Process, Intellectual Property, Pharmaceutical Analytics, Pharmaceutical Discovery, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, tagged #pharmanews, @Biotech News, Array Biopharma, Biotechnology in MA, BRAF, Colorectal cancer, M&A Brokers FINRA Guidance Investment Platforms for Private Placements Investment Platforms for Private Funds Crowdfunding, MEK inhibition, Mergers and acquisitions, Pfizer, pharma deals on June 17, 2019| Leave a Comment »

Pfizer buys out Array BioPharma for $11.4 Billion to beef up its oncology offerings Reporter: Stephen J. Williams, PhD As reported in FiercePharma.com: by Angus Liu | Jun 17, 2019 11:42am Three years after purchasing Medivation for $14.3 billion, Pfizer is back with another hefty M&A deal. And once again, it’s betting on oncology. In the first […]

Read Full Post »

The Vibrant Philly Biotech Scene: Proteovant Therapeutics Using Artificial Intelligence and Machine Learning to Develop PROTACs

Posted in Artificial Intelligence in CANCER, Artificial Intelligence in Medicine - Applications in Therapeutics, Autophagy, Autophagy-Modulating Proteins, BioIT: BioInformatics, Cell Biology, Signaling & Cell Circuits, Cell death pathways, Chemical Biology and its relations to Metabolic Disease, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Investment in Technological Breakthrough, Machine Learning, Proteolysis, Proteosome, Signaling, Signaling & Cell Circuits, Technology Transfer: Biotech and Pharmaceutical, Ubiquitin, Ubiquitinylation, Unfolded Protein Response (UPR), tagged Artificial intelligence, biotech startup, early ventures, Machine Learning, philadelphia, PROTAC, Proteovant, Therapeutic innovations, ubiquitin-proteosome, University of Michigan, Venture capital on October 26, 2021| Leave a Comment »

The Vibrant Philly Biotech Scene: Proteovant Therapeutics Using Artificial Intelligence and Machine Learning to Develop PROTACs Reporter: Stephen J. Williams, Ph.D. It has been a while since I have added to this series but there have been a plethora of exciting biotech startups in the Philadelphia area, and many new startups combining technology, biotech, and […]

Read Full Post »

Real Time Coverage @BIOConvention #BIO2019: Understanding the Voices of Patients: Unique Perspectives on Healthcare; June 4

Posted in Conference Coverage with Social Media, Curation, Patents, Patient Experience, Patient-centered Medicine, REAL TIME Conference Coverage Twitter's Hashtags and Handles per Presentation/session, Scientific & Biotech Conferences: Press Coverage, Voices of Patients and Healthcare Providers, tagged Conference Coverage with Social Media, defining patient experience, drivers of patient experience, exceeding patient expectations, healthcare, voices of patients on June 4, 2019| Leave a Comment »

Real Time Coverage @BIOConvention #BIO2019: Understanding the Voices of Patients: Unique Perspectives on Healthcare; June 4 11:00 AM Reporter: Stephen J. Williams, PhD @StephenJWillia2 Description The role of the patient has evolved dramatically over the past decade. Not only are patients increasingly more involved in their healthcare decision making, they are also passionate advocates […]

Read Full Post »

WordCloud Visualization of LPBI’s Top Sixteen Articles on CANCER in eight categories and by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com

Posted in Cancer and Current Therapeutics on July 30, 2020| 7 Comments »

WordCloud Visualization of LPBI’s Top Sixteen Articles on CANCER in eight categories and by Views at All Time and their Research Categories in the Ontology of PharmaceuticalIntelligence.com Curator: Stephen J. Williams, PhD and WordCloud Producers: Daniel Menzin, Noam Steiner-Tomer, Zach Day, Ofer Markman, PhD and Aviva Lev-Ari, PhD, RN Introduction (From Cancer Volume 1): Cancer […]

Read Full Post »

Three Expert Opinions on “The alarming rise of complex genetic testing in human embryo selection”

Posted in Gene Regulation and Evolution, Genetics & Innovations in Treatment, Genome Biology, Genomic Endocrinology, Genomic Testing: Methodology for Diagnosis, Reproductive Andrology, Embryology, Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics, Reproductive Biology & Bio Instrumentation on March 25, 2022| Leave a Comment »

Three Expert Opinions on “The alarming rise of complex genetic testing in human embryo selection” Reporter: Aviva Lev-Ari, PhD, RN Based on this articles three expert opinions where formed by the following domain knowledge experts and are presented, below. Expert Opinions on rise of complex genetic testing in human embryo selection ttps://www.nature.com/articles/d41586-022-00787-z Domain Knowledge Experts: […]